Physician profile
Andrew Leach
NPI 1699742320
$2,968.77
in general payments reported to CMS, 2019-2025
33 companies · $410 in 2025
The $410 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $708 · 2020: $403 · 2021: $462 · 2022: $520 · 2023: $257 · 2024: $208 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $862 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $862.15 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $428.74 | 2019-2023 | |
| Exeltis, USA INC. | $285.90 | 2020-2025 | Slynd |
| Astellas Pharma US INC | $263.68 | 2023-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $246.67 | 2019-2025 | |
| Daiichi Sankyo INC. | $246.00 | 2019-2021 | |
| Ethicon US, LLC | $189.70 | 2019-2021 | |
| Therapeuticsmd, INC. | $133.91 | 2019-2022 | |
| Coopersurgical, INC. | $124.71 | 2020-2025 | Paragard T 380a, Mara Console |
| Myovant Sciences INC. | $108.75 | 2021-2022 | |
| Millicent US INC | $88.79 | 2019-2024 | |
| Lupin INC. | $83.01 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $79.76 | 2021-2025 | |
| Evofem Biosciences, INC. | $59.22 | 2021-2022 | |
| Aspira Women'S Health INC | $54.90 | 2019 | |
| Biogen, INC. | $53.05 | 2025 | Zurzuvae |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $47.68 | 2023-2024 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $44.45 | 2021-2025 | Aptima |
| Organon LLC | $42.92 | 2021-2024 | |
| Vertical Pharmaceuticals, LLC | $41.85 | 2019 | |
| Dexcom, INC. | $40.94 | 2023-2025 | Dexcom G6 Transmitter |
| Roche Diagnostics Corporation | $37.82 | 2019 | |
| Avion Pharmaceuticals | $34.16 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $33.90 | 2025 | Myfembree |
| Amgen INC. | $32.20 | 2024-2025 | Evenity, Prolia, Prolia |
| Optumhealth Care Solutions, LLC | $28.84 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Amag Pharmaceuticals, INC. | $28.73 | 2019 | |
| Pfizer INC. | $20.02 | 2025 | |
| Meditrina | $17.15 | 2019 | |
| Davol INC. | $16.44 | 2020 | |
| Allergan, INC. | $15.22 | 2019 | |
| Mylan Pharmaceuticals INC. | $13.76 | 2020 | |
| Teleflex LLC | $13.38 | 2020 | |
| Merck Sharp & Dohme LLC | $12.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Leach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.